CIPLA

HealthcareDrug Manufacturers - Specialty & GenericLarge Cap
Cipla Limited

Cipla Limited, operating in the Healthcare sector as a Specialty & Generic Drug Manufacturer, manufactures, develops, sells, and distributes pharmaceutical products. The company of...

हिन्दी में

सिप्ला लिमिटेड, जो स्वास्थ्य सेवा क्षेत्र में एक विशेषता और जेनेरिक दवा निर्माता के रूप में कार्य करती है, फार्मास्युटिकल उत्पादों का निर्माण, विकास, बिक्री और वितरण करती है। यह कं...

₹1,311.3+0.79%1D
Previous trading day close · Data updates after market close
1W: -2.2%
1M: -4.5%
6M: +6.9%
1Y: -12.3%
68/100
AverageResearch Score
Market Cap
₹1.16L Cr
Large Cap
P/E Ratio
31.45
Fair
P/B Ratio
3.08
Premium
ROE
11.8%
Weak
ROCE
14.9%
Good
Debt / Equity
0.02
Low debt
Div. Yield
1.0%
Low yield
EV/EBITDA
18.48
Fair
52W Low: ₹1,165.7Current: ₹1,311.352W High: ₹1,673
At 29% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
77/100
Growth
Revenue, EPS, profit growth
66/100
Valuation
PE, PB, EV/EBITDA vs sector
52/100
Risk
Debt levels, volatility, coverage
89/100
News Sentiment
Recent news sentiment
46/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
31.45(Fair)
Forward P/E
20.69(Premium)
P/B Ratio
3.08(Premium)
P/S Ratio
3.77(Good)
EV/EBITDA
18.48(Expensive)
Dividend Yield
1.0%
5Y CAGR
8.3%(Moderate)
Revenue Growth
3.5%(Moderate)
Profitability
ROE
11.8%(Average)
ROCE
14.9%(Good)
ROA
9.7%(Average)
Net Margin
12.0%(Decent)
EBITDA Margin
22.9%
Financial Health
Debt to Equity
0.02(Low debt)
Current Ratio
3.44(Healthy)
Quick Ratio
2.50(Good)
Interest Coverage
109.31x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
26(Oversold)
RSI Exp (14)
15(Oversold)
MACD
-24.039(Bearish)
MACD Signal
-18.555
BB Position
12%(Lower band)
BB Width
9.12%(Normal)
ADX (14)
16.9(Sideways)
Williams %R
-85.0(Oversold)
MFI (14)
37(Neutral)
CCI (20)
-132(Oversold)
Stoch %K
15(Oversold)
ATR (14)
28.00(Avg True Range)
OBV (M)
-23.5(Negative)
1W OBV Chg
-3.6%(Decreasing)
Rel Volume
0.68x(Normal)
Volatility
22.1%(Moderate)
Max DD 1Y
-29.0%(Moderate)
Alpha (CAPM)
-18.00%(Underperforming)
Return vs Nifty
-1.8%(Below Nifty)
EMA 200
1402.9
EMA 50
1382.1
SMA 200
1374.3
vs SMA 50
-6.4%(Below SMA50)
vs SMA 200
-4.6%(Below SMA200)
Volume
6.66L
Avg Vol 3M
9.8L
Shareholding Pattern
Promoter
29.2%
Low stake
FII
22.6%
Strong foreign interest
DII / MF
32.0%
Strong MF interest
Share CIPLA
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.